2021
DOI: 10.1016/j.cgh.2020.08.040
|View full text |Cite
|
Sign up to set email alerts
|

Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
49
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(56 citation statements)
references
References 30 publications
4
49
0
3
Order By: Relevance
“…Preliminary data suggest that response to a low FODMAP diet may be predicted from baseline faecal bacterial profile and metabolomic activity, while a gluten-free diet may benefit those with serum antigliadin antibodies. [213][214][215]…”
Section: Guidelinesmentioning
confidence: 99%
“…Preliminary data suggest that response to a low FODMAP diet may be predicted from baseline faecal bacterial profile and metabolomic activity, while a gluten-free diet may benefit those with serum antigliadin antibodies. [213][214][215]…”
Section: Guidelinesmentioning
confidence: 99%
“…Based on these results, the authors proposed this class of antibody as a biomarker to identify IBS patients in whom GFD might improve symptoms. Future studies involving a higher number of patients are needed to confirm these preliminary results [102].…”
Section: Ncgs Among Patients Diagnosed As Ibsmentioning
confidence: 86%
“…Anti-gliadin AGA-IgG antibodies [61] have been reported in higher prevalence in NCGS, although the corresponding data in the healthy population were not evaluated. A recent paper reported that 22% of IBS patients were AGA positive [102]. In a randomized DBPC gluten re-challenge trial in patients with IBS, a GCD was associated with higher small bowel permeability, as assessed with the lactulose/mannitol test.…”
Section: Ncgs Among Patients Diagnosed As Ibsmentioning
confidence: 98%
“…Así mismo, si bien la dieta libre de gluten es esencial en el tratamiento de EC, incluso en el manejo de manifestaciones como la dermatitis herpetiforme y alteraciones psicológicas en estos pacientes, no hay suficientes evidencias para su utilización en otros padecimientos como la SGNC o el SII mismo 25 . A pesar de lo anterior, en un estudio en Canadá en pacientes con SII-Roma III, no seleccionados, aquellos que reportaron sensibilidad al gluten y que tenían antigliadinas IgA positivas respondieron en mayor proporción y de manera significativa a la dieta baja en gluten en comparación con los pacientes sin la presencia de antigliadinas IgA e IgG (75 vs. 38%) 26 . Además, una mayor proporción de pacientes con estos biomarcadores mejoraron el tránsito intestinal.…”
unclassified
“…Además, una mayor proporción de pacientes con estos biomarcadores mejoraron el tránsito intestinal. Más aún, la presencia de antigliadinas IgG fue un marcador predictor de la disminución de síntomas con la dieta libre de gluten en comparación con los pacientes sin este anticuerpo (RM: 128.9; IC 95%: 1.16-1,427.8; p = 0.04) 26 .…”
unclassified